FDA Plans Studies Of On-The-Market Medications
Under pressure since the 2004 withdrawal of Merck & Co.’s painkiller Vioxx, the FDA has asked health insurers, such as Kaiser Permanente, to collaborate on the studies.
One of the first studies will focus on ADHD medication. The study will seek to determine whether the stimulants that are the...
To view the full article, register now.